Prolong Pharmaceuticals, LLC

Alexion Pharmaceuticals Inc. has been left disappointed by top-line data from the Phase II/III registration trial for its first-in-class terminal complement inhibitor Soliris (eculizumab) in preve

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c

IN VITRO DIAGNOSTICS Arizona State University Arizona Technology Enterprises Biodesign Institute Provista Diagnostics Inc. Provista licenses biomarker technology from Arizona State University

Acquisitions DSM buys Roche's vitamins and fine chemicals division DSM NV (Heerlen, Netherlands) Roche (Basel, Switzerland) Roche is getting out of the vitamins, carotenoids, and fine chemicals busi